UBS Maintains a 'Buy' on CME Group (CME); Market Hails New Capital Return Strategy
CME Hot Sheet
Rating Summary:7 Buy, 7 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 18 | Down: 7 | New: 23
UBS maintains a 'Buy' on CME Group (NASDAQ: CME) price target lowered from $325 to $311.
UBS analyst says, "CME's shares gained significantly yesterday (+8%). We believe CME’s new capital return strategy drove the upside, as 4Q11 results were in line at best. While some will look at the significant increase in the company’s dividend as another sign that CME is no longer a growth story (a view we do not share), we believe the shares should move higher as a different investor base embraces the stock for the first time. We view CME as a cyclically-depressed growth story that can offer a significant dividend yield (4.5%; 3.4% ex variable part) given strong fundamentals."
UBS Lowering FY12 EPS to $18.32 from $19.00 and FY13 to $21.44 from $22.38.
For an analyst ratings summary and ratings history on CME Group click here. For more ratings news on CME Group click here.
Shares of CME Group closed at $266.01 yesterday, with a 52 week range of $224.69-$317.27.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
UBS analyst says, "CME's shares gained significantly yesterday (+8%). We believe CME’s new capital return strategy drove the upside, as 4Q11 results were in line at best. While some will look at the significant increase in the company’s dividend as another sign that CME is no longer a growth story (a view we do not share), we believe the shares should move higher as a different investor base embraces the stock for the first time. We view CME as a cyclically-depressed growth story that can offer a significant dividend yield (4.5%; 3.4% ex variable part) given strong fundamentals."
UBS Lowering FY12 EPS to $18.32 from $19.00 and FY13 to $21.44 from $22.38.
For an analyst ratings summary and ratings history on CME Group click here. For more ratings news on CME Group click here.
Shares of CME Group closed at $266.01 yesterday, with a 52 week range of $224.69-$317.27.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- Needham & Company Reiterates a 'Buy' on NetApp (NTAP); Solid 4Q Overshadowed by Conservative 1Q
- CME Group Inc. Announces Preliminary Results from its 2012 Annual Meeting of Shareholders
- UBS Raises Price Target and Estimates on PetSmart (PETM); Sees Sustained Sales and Margin Benefit
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
UBS, DividendSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
